Vistin Pharma ASA announced that at its AGM held on May 19, 2022, the shareholders approved the board of directors propose to get a power of attorney to pay out a dividend to shareholders for up to NOK 0.75 per share for 2021, until December 31, 2022, and is planned to be distributed as a repayment of paid-in capital (share premium).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22 NOK | -1.35% | -6.78% | -5.58% |
Apr. 24 | Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024 |
1st Jan change | Capi. | |
---|---|---|
-5.58% | 92.41M | |
+21.98% | 43.92B | |
+24.56% | 23.09B | |
+19.25% | 15.35B | |
+14.03% | 13.61B | |
+46.40% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.6B |
- Stock Market
- Equities
- VISTN Stock
- News Vistin Pharma ASA
- Vistin Pharma ASA Approves Dividend for 2021